In the hormone receptor-positive subgroup, HER2-low tumor had longer LRFS than HER2-zero tumor (univariate analysis, Bonferroni corrected p = 0.053, Supplementary Figure S4A; multivariate analysis, p = 0.023). The gene discussed is NR4A1; the disease is neoplasm.